Trial Profile
A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs MB 6 (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors MICROBIO Group
- 18 Jul 2018 New trial record